Title: Evaluation of Serum Cystatin-C and Serum Creatinine Levels in Type-2 DM

Authors:Krishan Kant Pandey, Dr Neelimia Singh, Dr Arun Raizada

 DOI:  http://dx.doi.org/10.18535/jmscr/v3i11.13

Abstract

Type-2 diabetes has become the most common metabolic disorder in India and is a growing problem with over 40 million diabetic subjects. The “Asian Indian phenotype” is associated with increased insulin resistance, greater abdominal adiposity despite lower body mass index, lower adiponectin and higher high sensitivity C - reactive protein levels and makes Asians more prone to diabetes. Among Indians, the onset of type 2 diabetes occurs at a younger age and hence, they are vulnerable to all the complications of diabetes due to longer duration of the disease. An overnight fasting blood sample was collected from both cases and controls and the samples were centrifuged and separated for the estimations. Estimations of fasting blood glucose, blood urea and serum creatinine were performed using the serum. Estimation of serum cystatin C was done by immunoturbidimetric method. The mean age of cases in this study was 56.16±10.47 with a body mass index of 25.7±4.15. The mean & S.D. of blood urea, serum creatinine & serum cystatin C were 36.88±12.48, 0.98±0.32 & 1.61±0.45 in cases. The study shows significant increase in serum cystatin C levels in diabetic individuals compared to controls. These finding that the measurement of serum cystatin C levels in type-2 DM as a marker of renal impairment.

Keywords: Type-2 DM, cyctatin C and marker of renal impairment.

References

1.      Salim Bastaki. Diabetes mellitus and its treatment. Int J Diabetes Metabol. 2005;13:111-34.

2.      Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario.   Indian J Medical Res. 2007 Mar;125:217-30.

3.      Daniel J. Moore, Justin M. Gregory, Yaa A. Kumah-Crystal, Jill H. Simmons. Mitigating micro- and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag. 2009;5:1015-30.

4.      Timothy C. Evans, Peter Capell. Diabetic nephropathy. Clin Diabetes. 2000;18(1):7.

5.      Piero Ruggenenti, Guiseppe Remuzzi. Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment? Nephrol Dial Transpalnt. 2000;15:1900-2.

6.      Ayodele OE1, Alebiosu CO, Salako BL. Diabetic nephropathy: a review of natural history, burden, risk factors and treatment. J Natl Med Assoc. 2004;96(11):1445-54.

7.      Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med. 2004;256:510-8.

8.      Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant. 2006;21:1855-62.

9.      Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children: a meta-analysis. Clin Biochem. 2007;40:383-91.

10.  Yun Kyung Jeon, Mi Ra Kim, Jung Eun Huh, Ji Young Mok, Sang Heon Song, Sang Soo Kim, et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 Diabetes. J Korean Med Sci. 2011;26:258-63.

11.  Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of GFR: history, indications and future research. Clin Biochem. 2005;38:1-8.

12.  Punya Krit Deb Barma, Salam Ranbir, Thangjam Premchand Singh. Clinical and biochemical profile of lean type 2 diabetes mellitus. Indian J Endocrinol Metab. 2011 Jul;15(1):40-3.

13.  Nazmu Saquib, Masuma Akter Khannum, Juliana Saquib, Suchi Anand, Glen M. Chertow. High prevalence of type 2 diabetes among urban middle class in Bangladesh. BMC Public Health. 2013;13:1032.

14.  Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, Batista MC. Is cystatin C a useful marker in the detection of diabetic kidney disease? Nephron Clin Pract. 2010;114(2):127-34.

15.  Bussychaert M, Joudi I, Wallemacq P, Hermans MP. Comparative performance of serum cystatin C versus serum creatinine in diabetic patients. Diabetes Metab. 2003;29:377-83.

16.  Richard J. MacIsaac, Erosha Premaratne, George Jerums. Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev. 2011 May;32:61-7.

Corresponding Author

Krishan Kant Pandey

Assistant Professor, Dept. Of Biochemistry,

Major .S.D. Singh Medical College Farrukhabad (U.P)  Pin- 209601